Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Catalent Pharma Solutions

From drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success. With over 75 years of experience, we have the deepest expertise, the broadest offerings, and the most innovative technologies to help you get more molecules to market faster, enhance product performance, and provide superior, reliable manufacturing results.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Catalent Pharma Solutions
14 Schoolhouse Road, Somerset, NJ, 08873, United States
+1 866 720 3148
Contact Catalent Pharma Solutions
Website

 Latest Content from PMHub 

Lucid team : because you’re worth it!

Press Releases | December 3, 2015 | Lucid Group Communications Limited

Lucid group reward the team for an amazing year

Why is behaviour change so difficult? By Patrick Ladbury, Communications Manager at the National Social Marketing Centre.

White Papers and Resources | December 3, 2015 | Say Communications

Patrick Ladbury nudges us to overcome the barriers to behaviour change. Read on to find out.

Blue Latitude Health wins PMEA 2015 Innovation award

Press Releases | November 30, 2015 | Blue Latitude Health

We are pleased to announce that Blue Latitude Health has won a PMEA 2015 award for our work with Eli Lilly and Company on the Lilly Medical Information Cascade. The...

DJM PAN Unlimited triumphs at IPA Best of Health Awards

Press Releases | November 29, 2015 | Health Unlimited

Multi-channel creative agency DJM PAN Unlimited has won three awards at this year’s IPA Best of Health Awards.

Lucid celebrate big wins at PMEA 2015

Press Releases | November 26, 2015 | Lucid Group Communications Limited

Success for Lucid at PMEA 2015

Lucid invests in their Futures programme with a new hire

Press Releases | November 20, 2015 | Lucid Group Communications Limited

Lucid Group continues their expansion

Janus kinase inhibitors are amongst the most read abstracts at the American College of Rheumatology 2015

Press Releases | November 19, 2015 | Lucid Group Communications Limited

Rheumatologists eagerly await trial data for Janus kinase inhibitors

Making a difference to patients with IBD

Press Releases | November 16, 2015 | Lucid Group Communications Limited

Changing lives with medical education

Lucid’s motivation to make a difference in medical education drives everything they do

Press Releases | November 11, 2015 | Lucid Group Communications Limited

Changing lives with medical education

Lucid Group meets with next generation MedEd talent at University of Oxford Internships Fair

Press Releases | November 9, 2015 | Lucid Group Communications Limited

Lucid Group will welcome interns in summer 2016